Vetter Serializes Product for South Korean Market

Vetter has manufactured the first commercial batches with single-use identification numbers in accordance with serialization requirements of the South Korean Ministry of Food and Drug Safety (MFDS). Vetter introduced its serialization service last year, and has now implemented product serialization for secondary packaging for a top pharmaceutical company. Vetter’s solution identifies the drugs on the folding boxes via a 2-D data matrix code with a serial number, GTIN, expiry date, and batch number.
 
In an effort to thwart counterfeit drugs and secure the supply chain, many regulatory authorities are demanding that the smallest packaging unit be marked with a single-use identification number. While South Korea has only asked for serialization on the folding package, China has legislated use of 1-D linear codes including aggregation with the shipping box.
 
“Together with our customer, we prepared for these requirements very early on,” says Thomas Otto, managing director at Vetter. “We have been active in filling and final packaging for the company for years. Thanks to our serialization service, our partner can now meet the regulatory requirements for South Korea. We are, however, also aware of the fact that regulatory requirements differ from one country to the next. Therefore, we offer pharma and biotech companies a wide range of options that will give them flexibility when reacting to different regulatory standards.”
 
Vetter provides services in secondary packaging, primary packaging and final assembly to accommodate various regulatory or market needs. The company’s serialization service includes a range of formats for serial numbers, different code systems, such as a 2-D data matrix codes, interfaces and reports, as well as various aggregation depths.